New Stock News | Wuhe and Boao submit applications to Hong Kong Stock Exchange

date
08:17 02/03/2026
avatar
GMT Eight
According to the disclosure on February 27 by the Hong Kong Stock Exchange, Beijing WooHaoBoao Pharmaceuticals Limited (hereinafter referred to as WooHaoBoao) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with Huatai International as its exclusive sponsor.
According to the disclosure by the Hong Kong Stock Exchange on February 27th, Beijing Wuheboa Pharmaceutical Co., Ltd. (hereinafter referred to as Wuheboa) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Huatai International as its exclusive sponsor. Wuheboa is a biopharmaceutical company that has been focused on natural drug innovation since its establishment in 2010, specializing in the research, industrialization, and commercialization of original new drugs with high technological barriers. At the same time, the company has developed a drug delivery system to overcome the technical bottlenecks of drug delivery in the body.